Urolithin A alleviates diabetes and pancreatic damage by activating the AKT/mTOR pathway to regulate insulin signaling and autophagy to reduce oxidation, inflammation and apoptosis in the pancreas of type 2 diabetic mice [27]. Here, AKT1 is linked to diabetes mellitus.